Profile data is unavailable for this security.
About the company
Microbot Medical Inc. is a pre-clinical medical device company. It specializes in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms include ViRob, TipCAT, LIBERTY and certain CardioSert assets. The ViRob is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The TipCAT is a disposable self-propelled locomotive device that is specially designed to advance tubular anatomy. LIBERTY is designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature. It is developing Self-Cleaning Shunt (SCSTM), for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH) using ViRob platform. It is developing the fully disposable robot for various endovascular interventional procedures using LIBERTY and CardioSert platforms. It is also focused on the development of a multi generation pipeline portfolio.
- Revenue in USD (TTM)0.00
- Net income in USD-13.12m
- Incorporated1988
- Employees17.00
- LocationMicrobot Medical Inc25 RECREATION PARK DR SUITE 108HINGHAM 02043United StatesUSA
- Phone+1 (908) 938-5561
- Fax+1 (302) 655-5049
- Websitehttp://www.microbotmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regen BioPharma Inc | 235.87k | 1.14m | 33.89m | 1.00 | -- | -- | -- | 143.68 | -0.0005 | -0.0005 | 0.00005 | -0.0017 | 0.2222 | -- | 0.9809 | 235,870.00 | 107.08 | -771.89 | -- | -- | -- | -- | 482.00 | -2,749.25 | -- | -- | -- | -- | 55.63 | 11.35 | -347.67 | -- | -- | -- |
| Comera Life Sciences Holdings Inc | 242.06k | -9.00m | 34.36m | 9.00 | -- | -- | -- | 141.94 | -1.36 | -1.36 | 0.0237 | 0.1602 | 0.0043 | -- | -- | -- | -15.44 | -- | -15.79 | -- | 59.08 | -- | -3,634.83 | -- | -- | -- | 0.00 | -- | -- | -- | 242.87 | -- | -- | -- |
| Corvus Pharmaceuticals Inc | 0.00 | -36.57m | 34.44m | 28.00 | -- | 0.4285 | -- | -- | -0.7989 | -0.7989 | 0.00 | 1.73 | 0.00 | -- | -- | 0.00 | -36.22 | -39.16 | -40.76 | -43.08 | -- | -- | -- | -- | -- | -4.44 | 0.00 | -- | -- | -- | -621.28 | -- | -70.40 | -- |
| Acurx Pharmaceuticals Inc | 0.00 | -12.56m | 34.61m | 3.00 | -- | 3.54 | -- | -- | -1.23 | -1.23 | 0.00 | 0.856 | 0.00 | -- | -- | 0.00 | -94.08 | -- | -103.34 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -177.12 | -- | -- | -- |
| Syros Pharmaceuticals Inc | 25.24m | -109.47m | 35.09m | 124.00 | -- | 1.13 | -- | 1.39 | -17.31 | -17.31 | 3.99 | 4.92 | 0.1403 | -- | 11.30 | 203,564.50 | -60.82 | -52.85 | -74.62 | -62.36 | -- | -- | -433.67 | -828.85 | -- | -- | 0.5684 | -- | 55.62 | 136.57 | -3.00 | -- | -11.72 | -- |
| Adamis Pharmaceuticals Corp | 734.47k | -31.57m | 35.28m | 15.00 | -- | 5.01 | -- | 48.03 | -0.205 | -0.2618 | 0.005 | 0.047 | 0.018 | 4.12 | 1.12 | 48,964.67 | -77.56 | -67.59 | -108.43 | -91.72 | -632.97 | 16.94 | -4,297.89 | -277.05 | 1.53 | -- | 0.00 | -- | -20.45 | -19.35 | 3.48 | -- | 58.81 | -- |
| Elite Pharmaceuticals Inc | 32.88m | 6.82m | 35.32m | 43.00 | 5.18 | 1.38 | 4.41 | 1.07 | 0.0067 | 0.0067 | 0.0325 | 0.0253 | 0.8419 | 2.47 | 8.96 | 764,610.00 | 17.45 | -1.46 | 21.22 | -1.88 | 46.23 | 45.72 | 20.72 | -2.28 | 3.43 | 99.19 | 0.3482 | -- | 27.11 | 27.33 | 74.87 | -18.35 | -14.71 | -- |
| AcelRx Pharmaceuticals Inc | 2.88m | 45.70m | 35.36m | 43.00 | 0.8326 | 1.07 | 0.7441 | 12.29 | 0.2883 | 0.2883 | 0.0213 | 0.225 | 0.0424 | 2.94 | 12.29 | 66,883.72 | 67.34 | -43.66 | 88.87 | -52.59 | -15.89 | -51.08 | 1,588.91 | -935.08 | 1.76 | -21.97 | 0.2298 | -- | -47.97 | -30.48 | 13.08 | -- | -13.26 | -- |
| Microbot Medical Inc | 0.00 | -13.12m | 35.40m | 17.00 | -- | 4.15 | -- | -- | -1.85 | -1.85 | 0.00 | 1.20 | 0.00 | -- | -- | 0.00 | -80.95 | -47.00 | -88.99 | -54.77 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.38 | -- | 22.51 | -- |
| Maia Biotechnology Inc | 0.00 | -14.77m | 35.54m | -- | -- | 4.11 | -- | -- | -1.48 | -1.48 | 0.00 | 0.7916 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -18.82 | 0.00 | -- | -- | -- | -88.41 | -- | -- | -- |
| CASI Pharmaceuticals Inc | 34.91m | -32.10m | 35.65m | 168.00 | -- | 0.5325 | -- | 1.02 | -2.32 | -2.32 | 2.52 | 4.92 | 0.265 | 3.14 | 4.36 | 207,767.90 | -23.77 | -35.38 | -32.14 | -43.33 | 58.39 | -- | -89.69 | -337.70 | 2.77 | -- | 0.0111 | -- | 99.25 | -- | 24.09 | -- | 133.52 | -- |
| Aikido Pharma Inc | 0.00 | -14.58m | 35.94m | 4.00 | -- | 0.3919 | -- | -- | -2.77 | -2.77 | 0.00 | 17.48 | 0.00 | -- | -- | 0.00 | -10.88 | -20.89 | -10.99 | -22.22 | -- | -- | -- | -1,985.08 | -- | -153.90 | 0.00 | -- | -- | -- | 41.87 | -- | 173.93 | -- |
| Cyclerion Therapeutics Inc | 1.90m | -48.43m | 36.57m | 32.00 | -- | 1.44 | -- | 19.27 | -1.12 | -1.12 | 0.0437 | 0.5833 | 0.0342 | -- | 16.72 | 59,312.50 | -87.31 | -133.29 | -106.93 | -172.00 | -- | -- | -2,551.69 | -4,296.24 | -- | -- | 0.00 | -- | 71.69 | -- | 33.62 | -- | -65.56 | -- |
| Lisata Therapeutics Inc | 0.00 | -24.57m | 36.68m | 27.00 | -- | 0.2299 | -- | -- | -6.13 | -6.13 | 0.00 | 20.40 | 0.00 | -- | -- | 0.00 | -25.27 | -35.43 | -26.17 | -43.42 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -237.01 | -- | -44.10 | -- |
| Mannatech, Inc. | 146.30m | 6.35m | 36.78m | 246.00 | 6.20 | 1.74 | 4.75 | 0.2514 | 3.10 | 3.10 | 71.34 | 11.08 | 2.39 | 2.32 | 661.99 | 594,711.40 | 10.36 | 4.13 | 22.45 | 7.88 | 78.26 | 79.08 | 4.34 | 1.67 | 0.8758 | 301.76 | 0.0248 | 56.85 | 5.52 | -2.39 | 57.20 | -- | -22.24 | 23.56 |
Data as of Sep 23 2022. Currency figures normalised to Microbot Medical Inc's reporting currency: US Dollar USD
10.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2022 | 266.82k | 3.75% |
| BlackRock Fund Advisorsas of 30 Jun 2022 | 151.03k | 2.13% |
| Contego Capital Group, Inc.as of 30 Jun 2022 | 100.00k | 1.41% |
| Dimensional Fund Advisors LPas of 30 Jun 2022 | 88.84k | 1.25% |
| Geode Capital Management LLCas of 30 Jun 2022 | 51.82k | 0.73% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2022 | 37.19k | 0.52% |
| SSgA Funds Management, Inc.as of 30 Jun 2022 | 26.07k | 0.37% |
| Renaissance Technologies LLCas of 30 Jun 2022 | 20.10k | 0.28% |
| The Bank of New York Mellon Corp. (Investment Management)as of 30 Jun 2022 | 15.50k | 0.22% |
| Cetera Advisor Networks LLCas of 30 Jun 2022 | 12.55k | 0.18% |
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
